Skip to the page

Data / Form D filings / Neos Therapeutics, Inc.

Neos Therapeutics, Inc.: Form D filings

Neos Therapeutics, Inc., a pharmaceuticals company in Grand Prairie, TX, filed 11 Form D notices with the SEC between 2009 and 2015. The latest, on February 20, 2015, reports $20.6 million sold of a $20.6 million offering to 27 investors.

Find out what Neos Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2940 N. HIGHWAY 360, SUITE 400, Grand Prairie, TX, 75050
Phone
(972) 408-1360
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1467652

The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 20, 2015Amendment$20,624,355$20,624,355$027Dec 30, 2014sec.gov
Jan 7, 2015New notice$15,000,000$8,000,000$7,000,00010Dec 30, 2014sec.gov
Apr 9, 2014New notice$2,500,000$2,500,000$03Mar 28, 2014sec.gov
Mar 4, 2014Amendment$15,500,170$15,500,170$025Dec 19, 2013sec.gov
Jan 2, 2014New notice$15,000,000$8,067,240$6,932,76012Dec 19, 2013sec.gov
Jul 16, 2012New notice$30,000,000$18,267,890$11,732,11041Jul 2, 2012sec.gov
Jun 9, 2011New notice$20,000,000$13,554,505$6,445,49548May 27, 2011sec.gov
Nov 23, 2009Amendment$50,000,000$24,195,000$25,805,00057Jun 19, 2009sec.gov
Oct 7, 2009Amendment$40,000,000$19,195,000$20,805,00056Jun 19, 2009sec.gov
Oct 7, 2009Amendment$40,000,000$19,145,000$20,855,00055Jun 19, 2009sec.gov
Jul 2, 2009New notice$40,000,000$14,570,000$25,430,00042Jun 19, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven LutzExecutive Officer
Carolyn SikesExecutive Officer
Arlen EwartExecutive Officer
Russ McMahenExecutive Officer
Stacie SwitzerExecutive Officer
Margaret CabanoExecutive Officer
Greg RobitailleDirector
Richard EisenstadtExecutive Officer
Alan HellerDirector
Asif MughalExecutive Officer
Mark TenglerExecutive Officer
Ralph IannelliDirector
Vipin GargExecutive Officer, Director
Bryant FongDirector
Edward SchnipperDirector
Dorothy EngelkingExecutive Officer

Other pharmaceuticals companies in Texas that filed recently

Every Form D from the week of Feb 16, 2015 · All recent filings in Texas · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Neos Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.